JCIS

Journal of Clinical and Investigative Surgery
ISSN: 2559-5555

DPSM
 

Vulvar basal cell carcinoma, a rare location

Cornelia Nitipir1,2, Iulian Slavu3, Cristina Orlov2, Raluca Tulin1, Luminita Tomescu3, Adrian Tulin1,3

1Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2Elias University Emergency Hospital, Department of Oncology, Bucharest, Romania
3Agrippa Ionescu Emergency Hospital, Department of General Surgery, Bucharest, Romania


J Clin Invest Surg. 2018; 3(1): 53-56. DOI: 10.25083/2559.5555/31.5356
Running title: Vulvar basal cell carcinoma, a rare location
Keywords: vulvar, basal cell carcinoma, chemotherapy, rare location


Abstract

Basal Cell Carcinoma is the most common human malignant neoplasm. Vulvar basal cell carcinoma is rare, accounting for less than 5% of all vulvar neoplasms. Vulvar basal cell carcinomas are usually diagnosed late because they are often asymptomatic and tend to grow at slow rates. They are usually diagnosed late because they are often asymptomatic. However, these tumours may appear in areas which are normally covered with ultraviolet light.

We present the case of a 60 years old woman diagnosed with invasive breast cancer for which she underwent surgery followed by chemotherapy and radiotherapy. The patient presented to our department with an ulcerated vulvar lesion. On inspection, the tumour measured 3/2 cm and was located on the left labium majus. The biopsy confirmed the diagnosis of vulvar basal cell carcinoma and a wide local excision was performed with no relapse at one year.

In conclusion, early detection of BCC’s is critical to allow complete surgical cure so any abnormality on the vulva should be biopsied. A wide safety margin of 1cm should be achieved when resecting the tumour and the physician should keep in mind that the BCC’s of the vulva has a high recurrence rate. Previous chemotherapy is not associated with this type of non-melanoma skin cancer.

e-Repository